Community Health Systems (NYSE:CYH) Rating Increased to Hold at Wall Street Zen

Community Health Systems (NYSE:CYH) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Sunday.

A number of other research firms also recently weighed in on CYH. Weiss Ratings raised Community Health Systems from a “sell (d)” rating to a “sell (d+)” rating in a research report on Thursday, July 2nd. Truist Financial reduced their price objective on Community Health Systems from $3.50 to $3.00 and set a “hold” rating for the company in a research report on Thursday, April 23rd. Barclays cut Community Health Systems from an “equal weight” rating to an “underweight” rating and set a $3.00 price objective on the stock. in a research report on Wednesday. Finally, Zacks Research cut Community Health Systems from a “strong-buy” rating to a “hold” rating in a research report on Friday, April 24th. One equities research analyst has rated the stock with a Buy rating, four have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, Community Health Systems has an average rating of “Reduce” and a consensus price target of $3.28.

Community Health Systems Stock Down 3.6%

Shares of CYH stock traded down $0.14 during trading hours on Friday, reaching $3.56. 840,717 shares of the company’s stock were exchanged, compared to its average volume of 1,491,431. The business has a fifty day moving average price of $3.05 and a 200-day moving average price of $3.14. The stock has a market capitalization of $502.38 million, a P/E ratio of 1.04 and a beta of 1.81. Community Health Systems has a fifty-two week low of $2.38 and a fifty-two week high of $4.43.

Community Health Systems (NYSE:CYH) last released its earnings results on Tuesday, April 21st. The company reported ($0.48) EPS for the quarter, missing the consensus estimate of ($0.18) by ($0.30). Community Health Systems had a net margin of 3.78% and a negative return on equity of 7.62%. The company had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.89 billion. During the same quarter in the previous year, the company earned ($0.03) earnings per share. Community Health Systems’s revenue for the quarter was down 6.1% compared to the same quarter last year. Community Health Systems has set its FY 2026 guidance at -0.600-0.000 EPS. As a group, research analysts expect that Community Health Systems will post -0.58 EPS for the current fiscal year.

Hedge Funds Weigh In On Community Health Systems

A number of hedge funds have recently modified their holdings of CYH. Royal Bank of Canada lifted its position in shares of Community Health Systems by 601.9% during the 4th quarter. Royal Bank of Canada now owns 9,286 shares of the company’s stock worth $29,000 after buying an additional 7,963 shares during the period. Lazard Asset Management LLC bought a new position in shares of Community Health Systems during the fourth quarter valued at $34,000. Wealthcare Advisory Partners LLC acquired a new stake in shares of Community Health Systems in the 4th quarter valued at $35,000. Valeo Financial Advisors LLC bought a new stake in shares of Community Health Systems in the 4th quarter worth about $39,000. Finally, Quarry LP bought a new position in Community Health Systems during the 3rd quarter valued at about $39,000. 84.99% of the stock is owned by institutional investors and hedge funds.

Community Health Systems Company Profile

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.